Category archives: Pharmacy

Riboflavin as a bioorthogonal photocatalyst

Riboflavin as a bioorthogonal photocatalyst

ChemistryCondensed matterDIPC BiochemistryDIPC PhotochemistryPharmacy

By DIPC

The combination of catalysis and bioorthogonality promises have an impact on drug discovery and bioimaging. Bioorthogonality, a term coined by Carolyn R. Bertozzi in 2003, refers to any chemical reaction that can occur inside of living systems without interfering with native biochemical processes. Hence, catalytic turnover can boost the efficiency of bioorthogonal chemical reactions, unveiling […]

Combatting antimicrobial resistance with a ruthenium-based photorelease antimicrobial therapy

Combatting antimicrobial resistance with a ruthenium-based photorelease antimicrobial therapy

ChemistryCondensed matterMedicineMicrobiologyPharmacy

By DIPC

Antimicrobial resistance is a complex problem that contributes to health and economic losses worldwide. Resistance to antimicrobial therapies reduces the effectiveness of current drugs, leading to increased morbidity, mortality, and health care expenditure. Because globalization increases the vulnerability of any country to diseases occurring in other countries, resistance presents a major threat to global public […]

How drug discovery works: finding new strategies against Kaposi’s sarcoma

How drug discovery works: finding new strategies against Kaposi’s sarcoma

BiomedicineMedicinePharmacy

By Isabel Perez Castro

15% of human cancers worldwide may be attributed to viruses, 1 with both DNA and RNA viruses being capable of causing the disease. Epstein-Barr virus, human papilloma virus, hepatitis B virus, and human herpes virus-8 are the four DNA viruses capable of causing the development of human cancer, whereas human T lymphotrophic virus type 1 […]

Melodrama with happy ending for Duchenne Muscular Dystrophy patients

Melodrama with happy ending for Duchenne Muscular Dystrophy patients

BiologyBiomedicineGeneticsMedicinePharmacy

By Sergio Laínez

Patients suffering from rare diseases (defined by the European as those affecting less than 5 in 10000 people) have traditionally been overlooked by pharmaceutical companies. They are usually looking for the next blockbuster drug, so the lack of a large patient pool means they may not generate the revenue needed to justify the R&D financial […]

The Dark Side of Al(III) Chelation Therapy:  A New Computational Hope

The Dark Side of Al(III) Chelation Therapy: A New Computational Hope

ChemistryPharmacyTCCM

By TCCM

Author: Gabriele Dalla Torre is a Ph.D. student (ITN-EJD-TCCM) at UPV/EHU Aluminum is the third most abundant element in Earth’s crust, after oxygen and silicon. As a consequence, during the last century, human intervention has made aluminum so highly bioavailable that C. Exley, one of the leading researcher on Al(III) biochemistry, stated that we are […]

Are we close to find a treatment for Alzheimer´s disease?

Are we close to find a treatment for Alzheimer´s disease?

MedicineNeurobiologyPharmacy

By Invited Researcher

Author: Estibaliz Capetillo-Zarate got her Ph.D. from Bonn University in 2006. Since 2007 she has worked for the Weil Cornell Medical College. Currently she is an Ikerbasque Research Fellow affiliated to UPV/EHU and the Achucarro Basque Center for Neuroscience. She investigates the role of neurons and microglia in Alzheimer’s disease. We might be still a […]

More pain than expected

More pain than expected

MedicineNeurobiologyPharmacy

By José Ramón Alonso

Pain is an unpleasant sensory and emotional experience associated with actual or potential tissue damage. It is the most common reason for physician consultation in most developed countries and after disease/damage of the nervous system is predominantly treated with opioids. Opioids are medications that relieve pain. They reduce the intensity of pain signals reaching the […]